Quinnova raises series B to expand topical delivery platform
This article was originally published in Scrip
Executive Summary
Quinnova Pharmaceuticals has raised $17.4 million in a series B round led by Safeguard Scientifics. Existing investors Thomas, McNerney & Partners and HIG BioVentures also participated.